Cargando…
CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis
CCL14 is a member of CC chemokines and its role in hepatocellular carcinoma (HCC) is still unknown. In this study, CCL14 expression were analyzed by tissue microarray (TMA) including 171 paired tumor and peritumor tissues of patients from Zhongshan Hospital of Fudan University. We found for the firs...
Autores principales: | Zhu, Mengxuan, Xu, Weiyue, Wei, Chuanyuan, Huang, Jing, Xu, Jietian, Zhang, Yuye, Zhao, Yan, Chen, Jie, Dong, Shuangshuang, Liu, Binbin, Liang, Chunmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805940/ https://www.ncbi.nlm.nih.gov/pubmed/31641099 http://dx.doi.org/10.1038/s41419-019-1966-6 |
Ejemplares similares
-
NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated With CCL5 and CXCL9 in HCC Patients
por: Wang, Chengpan, et al.
Publicado: (2022) -
α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014) -
Sleep Deprivation Disturbs Immune Surveillance and Promotes the Progression of Hepatocellular Carcinoma
por: Huang, Jing, et al.
Publicado: (2021) -
Sleep Disturbance Affects Immune Factors in Clinical Liver Cancer Patients
por: Wang, Zuoyun, et al.
Publicado: (2022) -
DEC2 Serves as Potential Tumor Suppressor in Breast Carcinoma
por: Fang, Wentong, et al.
Publicado: (2020)